With Dr Ben Sessa (UK)
Date: Fri 17 November 2023 @ 10:00am
Location: Sydney University, Susan Wakill Health Building, Seminar Room 322
Don’t miss out – Get your tickets early!
Half day workshop presented by Mind Medicine Australia featuring Dr Ben Sessa (UK):
A limited number of Medical and Allied Health Students may also register for these very special workshops.
Dr Sessa has been at the forefront of psychedelic research for over 15 years through his affiliations with Bristol University and Imperial College London, under the auspices of Professor David Nutt. He brings a wealth of knowledge to this fast developing field in Australia.
In this workshop, Dr Sessa (UK) will explore how psychedelic-assisted therapies works by explaining:
Who is this workshop for?
This workshop is for any professional who wants to learn more about the rapidly emerging field of psychedelic medicine and the use of psychedelic-assisted therapies in clinical practice. This is a rare opportunity to learn from a global clinician and researcher in the field. It will provide you with knowledge and skills to more effectively educate your clients and colleagues about these newly available transformational therapies.
It is of even greater value for those who are interested in transitioning to work in the psychedelic medicine space now or in the future.
Tickets are strictly limited and early bird ticket offer ends on October 20. Please register now before you miss out.
EVENT DETAILS
DATE: Friday 17 November 2023
TIME: 10:00am until 1:00pm workshop with catered lunch from 1:00pm-2:00pm
LOCATION: Sydney University, Susan Wakill Health Building, Seminar Room 322
MBBS, B.SC, MRC PSYCH
For over 15 years Dr Ben Sessa has been at the forefront of psychedelic and cannabis research and clinical medicine in the UK through his affiliations with Imperial College London. Ben qualified as a medical doctor from UCL in 1997 and went on to specialise in psychiatry. For 25 years he has worked as a consultant child and adolescent psychiatrist with young people and adult patients in the field of addictions and trauma-related psychiatry.
Ben started studying psychedelics as a junior doctor and has taken part in research projects at Bristol University, Cardiff University and Imperial College London with LSD, psilocybin, DMT, ketamine and MDMA – receiving and/or administering all of these compounds in legal research settings.
One of the first doctors to develop the field of contemporary psychedelic research in the UK, he was the former co-founder, former CEO, and subsequently the former Head of Psychedelic Medicine at Awakn Life Sciences, a Bio-Tech company carrying out psychedelic research into addictions. Awakn opened four clinical centres in the U.K. and Europe, providing psychedelic psychotherapy with ketamine, for a wide range of psychiatric indications, as well as an extensive R&D psychedelic research program.
Ben was one of the first Medical Cannabis psychiatric prescribers in the UK.
Ben is a trained MDMA, ketamine and psilocybin therapist. He has led research into MDMA-assisted therapy for Alcohol Use Disorder and is published widely in the academic and medical press.
Ben is the co-founder and past president of the Breaking Convention conference. He is the author of The Psychedelic Renaissance (2012/2017), the novel ‘To Fathom Hell or Soar Angelic’ (2015) and Altered States (2021). Ben lives and works in Bristol, UK.
Website: www.drsessa.com
Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.